Report

Global Oncolytic Virus Immunotherapy Market Size study, by Type (Engineering Oncolytic Viruses and Wild-Type Oncolytic Viruses), By Application (Hospitals, Clinics and Ambulatory Surgical Centers) and Regional Forecasts 2020-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
1.2.1. Oncolytic Virus Immunotherapy Market, by Region, 2018-2027 (USD Million)
1.2.2. Oncolytic Virus Immunotherapy Market, by Type 2018-2027 (USD Million)
1.2.3. Oncolytic Virus Immunotherapy Market, by Application 2018-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Oncolytic Virus Immunotherapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Oncolytic Virus Immunotherapy Market Dynamics
3.1. Oncolytic Virus Immunotherapy Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Oncolytic Virus Immunotherapy Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Oncolytic Virus Immunotherapy Market, by Type
5.1. Market Snapshot
5.2. Global Oncolytic Virus Immunotherapy Market by Type, Performance - Potential Analysis
5.3. Global Oncolytic Virus Immunotherapy Market Estimates & Forecasts by Type 2017-2027 (USD Million)
5.4. Oncolytic Virus Immunotherapy Market, Sub Segment Analysis
5.4.1. Engineering Oncolytic Viruses
5.4.2. Wild-Type Oncolytic Viruses
Chapter 6. Global Oncolytic Virus Immunotherapy Market, by Application
6.1. Market Snapshot
6.2. Global Oncolytic Virus Immunotherapy Market by Application, Performance - Potential Analysis
6.3. Global Oncolytic Virus Immunotherapy Market Estimates & Forecasts by Application 2017 -2027 (USD Million)
6.4. Oncolytic Virus Immunotherapy Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Clinics
6.4.3. Ambulatory Surgical Centers
Chapter 7. Global Oncolytic Virus Immunotherapy Market, Regional Analysis
7.1. Oncolytic Virus Immunotherapy Market, Regional Market Snapshot
7.2. North America Oncolytic Virus Immunotherapy Market
7.2.1. U.S. Oncolytic Virus Immunotherapy Market
7.2.1.1. Type breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Oncolytic Virus Immunotherapy Market
7.3. Europe Oncolytic Virus Immunotherapy Market Snapshot
7.3.1. U.K. Oncolytic Virus Immunotherapy Market
7.3.2. Germany Oncolytic Virus Immunotherapy Market
7.3.3. France Oncolytic Virus Immunotherapy Market
7.3.4. Spain Oncolytic Virus Immunotherapy Market
7.3.5. Italy Oncolytic Virus Immunotherapy Market
7.3.6. Rest of Europe Oncolytic Virus Immunotherapy Market
7.4. Asia-Pacific Oncolytic Virus Immunotherapy Market Snapshot
7.4.1. China Oncolytic Virus Immunotherapy Market
7.4.2. India Oncolytic Virus Immunotherapy Market
7.4.3. Japan Oncolytic Virus Immunotherapy Market
7.4.4. Australia Oncolytic Virus Immunotherapy Market
7.4.5. South Korea Oncolytic Virus Immunotherapy Market
7.4.6. Rest of Asia Pacific Oncolytic Virus Immunotherapy Market
7.5. Latin America Oncolytic Virus Immunotherapy Market Snapshot
7.5.1. Brazil Oncolytic Virus Immunotherapy Market
7.5.2. Mexico Oncolytic Virus Immunotherapy Market
7.6. Rest of The World Oncolytic Virus Immunotherapy Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Merck
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Amgen
8.2.3. TILT Biotherapeutics
8.2.4. Oncorus
8.2.5. Sorrento Therapeutics
8.2.6. Shanghai Sunway Biotech
8.2.7. BioVex, Inc.
8.2.8. Cold Genesys, Inc.
8.2.9. DNAtrix Therapeutics
8.2.10. Genelux Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption